Long non-coding RNAs in the gastric juice of gastric cancer patients

• Published in: Pathology, research and practice Vol. 214; no. 9; pp. 1239 - 1246
• Main Authors: Virgilio, Edoardo, Giarnieri, Enrico, Giovagnoli, Maria Rosaria, Montagnini, Monica, Proietti, Antonella, D’Urso, Rosaria, Mercantini, Paolo, Balducci, Genoveffa, Cavallini, Marco
• Format: Journal Article
• Language: English
• Published: Germany Elsevier GmbH 01-09-2018
• Subjects: Biomarkers, Tumor - analysis; Biomarkers, Tumor - genetics; Gastric cancer; Gastric juice; Gastric Juice - chemistry; Humans; lncRNAs; Long non coding RNA; RNA, Long Noncoding - analysis; Sensitivity and Specificity; Stomach Neoplasms - diagnosis; Stomach Neoplasms - pathology; lncRNAs; Long non coding RNA; GJ; Gastric cancer; Gastric juice
• ISSN: 0344-0338; 1618-0631
• DOI: 10.1016/j.prp.2018.07.023

Differently from other digestive malignancies, gastric cancer (GC) carcinogenesis seems more heterogeneous and unclear. This entails failing in identification of reliable serum tumor markers for screening early GC (EGC) as well as persisting ominous prognosis of this disease. Recently, investigation of human noncoding genome, especially long noncoding molecules (lncRNAs), has provided promising data. As for GC, however, since the current information on GC-specific lncRNAs is still scarce and comes largely from analyses performed on tissue or serum of affected patients, we decided to review the current literature dealing with expression of such molecules in the gastric juice (GJ) of GC patients. In the case of GC, in fact, several cytological and molecular works have already demonstrated GJ to be an interesting biological material for improving clinicopathologic and prognostic knowledge of this cancer.
For this review, we burrowed into the literature on lncRNAs expressed in GJ of GC patients. PubMed, Science Direct, Scopus, Web of Science, Google Scholar and ResearchGate were the search engines entertained. As of 2018, only seven studies have been reported. LINC00152, AA174084, UCA1, RMRP, ABHD11-AS1, LINC00982 and H19 were the GJ lncRNAs examined.
Following our review, we can conclude that, due to their high specificity and reliability, GJ lncRNAs should deserve a prominent role in the field of GC research: importantly, they could be used for screening EGC, ameliorating the existing methods of staging (which are still far from being completely accurate), improving the prognostic capacity of the current diagnostic armamentarium and, finally, providing new and valuable therapeutic targets.